Transforming the treatment of hematologic malignancies

Mayo Clinic's multidisciplinary team of experts discusses hematologic malignancies and the latest developments in the treatment of these cancers. Asher A. Chanan-Khan, M.D., M.B.B.S., and Carrie A. Thompson, M.D., explore Mayo Clinic's approach to individualized care for each patient.

The complexities of hematologic malignancies make diagnosis and determination of individualized treatment plans for patients with cancers such as leukemia, lymphoma and myeloma difficult to navigate. Advancements in treatment options, however, offer patients a greater chance of survival. Treatments such as targeted therapies, immunotherapies and stem cell transplant can lead the way to survivorship.

Video content outline:

Mayo Clinic expertise (0:50)
Advancements in the treatment of hematological malignancies (1:26)
Individualized treatment plans (1:50)
Immunotherapies (2:30)
Stem cell transplant (3:21)
Survivorship (4:29)
Collaboration with referring providers (5:01)


March 16, 2017

Created by

Mayo Clinic